About Vision
In 1997, after 31 years of varied experience with Pfizer and Warner, Dilip G. Shah sought early retirement from Pfizer to start Vision Consulting Group to assist clients in evolving investor-friendly public policies, to facilitate market share expansion, to help new companies entering the Indian Market, and advise pharmaceutical and consumer goods companies in their strategic planning. The unique perspective required to handle these key facets of doing business in India was developed over three decades of hands-on experience:

• The foundation years (1966-78) in organization & methods, systems design & development and internal audit.
• The challenging years (1978-87) of working with the government, opinion leaders and media.
• The pay-off year (1988-97) of responsibilities for strategic planning and implementation, viz. business development, acquisition, asset utilization, divestment, distribution operations, administrative efficiencies, the application of information technology to improve decision making, facilities planning and project management.

The last five-year period (1992-1997) was very eventful as a number of strategic initiatives changed the face of Pfizer in India. Sales doubled from Rs 1.4 bn to Rs 2.6 bn, while profit before tax rose almost 11 times, from Rs 27 mn to Rs 298 mn. That too after payment of Rs 56 mn to the parent company towards royalty and technical know-how fees.

About Mr. Dilip G Shah

Mr. Dilip G Shah, CEO of Vision Consulting Group, a firm specialized in strategic planning, has 37 years' varied experience in the pharmaceutical industry.

In addition, he currently holds the following positions:

• Member of the Management Board of the International Generic Pharmaceutical Alliance (IGPA)
  
  
• Secretary-General of Indian Pharmaceutical Alliance (IPA), an association of 11 large research based national companies. Together they share 30 percent of the domestic market, account for one third of exports and contribute 90 per cent of R & D spending in the pharmaceutical industry.
  
  
• Co-chairman of the FICCI's Committee on Pharmaceuticals
  
  
• Member of the CII's Committee on Drugs & Pharmaceuticals
  
  
• Member of the Board of Advisors of:
  - Express Pharma Pulse (Weekly)
  - Pharmabiz.com (Weekly)
  
  
• Member of the Advisory Panel for the Business Briefing: PharmaGenerics, U.K.
  
  
• Editor, Asia and India, Journal of Generic Medicines, U.K.
  
  
• Member of the Board of Directors of Emcure Pharmaceuticals Limited and Zuventus Healthcare Limited.

Author of the first book on "Drug Pricing in India" and occasional contributor to business press, he graduated from the premier business school in India, Indian Institute of Management(IIM), Ahmedabad, and has been a guest faculty for their Management Development Programmes.

Know More